Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities:
Net income	$ 4,601	$ 4,500
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	959	856
Provision for bad debts	(164)	(161)
Compensatory element of stock issuances		7
Stock issued for costs and expenses		2,239
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(1,297)	(1,675)
Notes receivable		12
Inventories	(64)	(140)
Prepaid expenses and other current assets	65	26
Other assets	(5)	(63)
Increase (decrease) in operating liabilities, net:
Accounts payable	183	50
Other current liabilities	(462)	(2,218)
Customer advances	(51)	(132)
Billings in excess of costs and estimated earnings on completed contracts		(30)
Other liabilities	(25)	92
Due to related medical practices		(9)
Net cash provided by operating activities	3,740	3,354
Cash Flows from Investing Activities:
Purchases of property and equipment	(665)	(599)
Cost of patents	(30)	(43)
Net cash used in investing activities	(695)	(642)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(50)	(1,410)
Additional Acquisition Costs	(58)
Distributions to noncontrolling interests	(1,740)	(1,837)
Repayment of notes receivable from employee stockholders	2	1
Net cash used in financing activities	(1,846)	(3,246)
Net (Decrease) Increase in Cash and Cash Equivalents	1,199	(534)
Cash and Cash Equivalents - Beginning of Period	10,140	8,528
Cash and Cash Equivalents - End of Period	$ 11,339	$ 7,994